• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗术后支架内再狭窄的研究进展

Elevation of the serum total and free prostate specific antigen levels after stent implantation in patients with coronary artery disease.

机构信息

Department of Cardiology, University of Mersin School of Medicine, Mersin, Turkey.

出版信息

Swiss Med Wkly. 2009 Nov 14;139(45-46):672-5. doi: 10.57187/smw.2009.12759.

DOI:10.57187/smw.2009.12759
PMID:19950034
Abstract

BACKGROUND

Prostate specific antigen (PSA) is the most important biochemical marker in the diagnosis and follow-up of patients with prostate cancer. In recent years, a relationship between PSA levels and cardiovascular conditions has been described. However, no study has investigated the PSA levels after coronary stenting.

AIM

To investigate the impact of coronary stent implantation on serum total PSA (tPSA) and free PSA (fPSA) levels.

METHODS

This study involved 60 men who underwent coronary angiography for suspected coronary artery disease. Of these, 25 were diagnosed as having angiographically normal coronary arteries (Group 1) and 35 underwent coronary stent implantation (Group 2). Serum tPSA and fPSA levels and f/tPSA ratios were determined in all patients immediately before the intervention and 24 hours and 30 days after the procedure.

RESULTS

In Group 1, there was no statistically significant change in the values of tPSA, fPSA and f/tPSA ratio before and after coronary angiography (p >0.05). In Group 2, tPSA and fPSA values 24 hours after stent implantation were significantly higher than the values at the baseline (p <0.01), whereas f/tPSA ratio did not change (p >0.05). Compared with the baseline, there was no statistically significantly difference in the PSA values 30 days after stent implantation (p >0.05).

CONCLUSIONS

This study demonstrated that serum tPSA and fPSA levels are increased after coronary stent implantation, but f/tPSA ratio is not affected. The findings suggest that serum tPSA and fPSA levels should not be used for the diagnosis of prostate cancer during the first 30 days after coronary stenting.

摘要

背景

前列腺特异抗原(PSA)是诊断和随访前列腺癌患者的最重要的生化标志物。近年来,已经描述了 PSA 水平与心血管状况之间的关系。然而,尚无研究调查过冠状动脉支架置入术后的 PSA 水平。

目的

研究冠状动脉支架置入对血清总 PSA(tPSA)和游离 PSA(fPSA)水平的影响。

方法

这项研究涉及 60 名因疑似冠状动脉疾病而行冠状动脉造影的男性。其中,25 名患者被诊断为冠状动脉造影正常(1 组),35 名患者接受了冠状动脉支架置入术(2 组)。所有患者在介入前、术后 24 小时和 30 天测定血清 tPSA 和 fPSA 水平和 f/tPSA 比值。

结果

在 1 组中,冠状动脉造影前后 tPSA、fPSA 和 f/tPSA 比值无统计学显著变化(p>0.05)。在 2 组中,支架置入后 24 小时 tPSA 和 fPSA 值明显高于基线值(p<0.01),而 f/tPSA 比值没有变化(p>0.05)。与基线相比,支架置入后 30 天 PSA 值无统计学显著差异(p>0.05)。

结论

本研究表明,冠状动脉支架置入后血清 tPSA 和 fPSA 水平升高,但 f/tPSA 比值不受影响。研究结果表明,在冠状动脉支架置入后 30 天内,不应使用血清 tPSA 和 fPSA 水平来诊断前列腺癌。

相似文献

1
Elevation of the serum total and free prostate specific antigen levels after stent implantation in patients with coronary artery disease.经皮冠状动脉介入治疗术后支架内再狭窄的研究进展
Swiss Med Wkly. 2009 Nov 14;139(45-46):672-5. doi: 10.57187/smw.2009.12759.
2
Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA.与总前列腺特异性抗原(PSA)和游离PSA百分比相比,血清中α1-抗糜蛋白酶-PSA复合物的测定并不能改善良性前列腺增生和前列腺癌之间的鉴别。
Urology. 1999 Jun;53(6):1160-7; discussion 1167-8. doi: 10.1016/s0090-4295(99)00080-1.
3
Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.组织学炎症对无临床可检测前列腺癌患者血清总前列腺特异性抗原和游离前列腺特异性抗原值的影响。
Korean J Urol. 2014 Aug;55(8):527-32. doi: 10.4111/kju.2014.55.8.527. Epub 2014 Aug 8.
4
Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.游离、复合及总前列腺特异性抗原的各种组合用于检测前列腺癌的比较。
Eur Urol. 2000 Oct;38(4):380-7. doi: 10.1159/000020312.
5
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?慢性透析对血清前列腺特异性抗原(PSA)、游离PSA及游离/总PSA比值的影响:接受长期透析的患者中前列腺癌检测是否受到影响?
Urology. 1999 Jun;53(6):1169-74. doi: 10.1016/s0090-4295(99)00010-2.
6
Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.游离前列腺特异性抗原、α1抗糜蛋白酶结合型前列腺特异性抗原及复合前列腺特异性抗原在前列腺癌诊断中临床有效性的比较
Eur Urol. 2001 Jan;39(1):57-64. doi: 10.1159/000052413.
7
Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.血清总前列腺特异性抗原在4.1至10 ng/mL之间的男性重复前列腺活检中前列腺癌的预测因素。
Int J Urol. 2003 Apr;10(4):201-6. doi: 10.1046/j.0919-8172.2003.00605.x.
8
The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer.不同形式的前列腺特异性抗原及其比值在前列腺癌患者中的预后价值。
BJU Int. 1999 Dec;84(9):1021-7. doi: 10.1046/j.1464-410x.1999.00345.x.
9
Percent free PSA as an additional measure in a prostate cancer screen.游离前列腺特异抗原百分比作为前列腺癌筛查的一项附加指标。
Clin Lab Sci. 2001 Spring;14(2):102-7.
10
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.在血清中检测人腺激肽释放酶2以及游离和总前列腺特异性抗原用于前列腺癌的半年一次筛查。
J Urol. 2003 Oct;170(4 Pt 1):1169-74. doi: 10.1097/01.ju.0000086640.19892.0b.

引用本文的文献

1
Exploration of Serum Prostatic Specific Antigen Level in Enlarged Prostate with its Histopathological Correlation.前列腺增生患者血清前列腺特异性抗原水平及其组织病理学相关性研究
J Pharm Bioallied Sci. 2022 Jul;14(Suppl 1):S880-S883. doi: 10.4103/jpbs.jpbs_893_21. Epub 2022 Jul 13.
2
Association between prostate specific antigen levels and coronary artery angioplasty.前列腺特异性抗原水平与冠状动脉血管成形术之间的关联。
J Renal Inj Prev. 2016 Dec 15;6(2):132-136. doi: 10.15171/jrip.2017.26. eCollection 2017.
3
Prospective investigation of change in the prostate-specific antigens after various urologic procedures.
各种泌尿外科手术后前列腺特异性抗原变化的前瞻性研究。
Clin Interv Aging. 2015 Jul 29;10:1213-8. doi: 10.2147/CIA.S84570. eCollection 2015.
4
Perioperative prostate specific antigen levels among coronary artery bypass grafting patients: Does extracorporeal circulation and body temperature induce prostate specific antigen levels alterations?冠状动脉搭桥手术患者围手术期前列腺特异性抗原水平:体外循环和体温会导致前列腺特异性抗原水平改变吗?
Urol Ann. 2015 Jan-Mar;7(1):58-62. doi: 10.4103/0974-7796.148619.
5
Prostate-specific antigen kallikrein and the heart.前列腺特异性抗原激肽释放酶与心脏。
World J Cardiol. 2009 Dec 31;1(1):23-5. doi: 10.4330/wjc.v1.i1.23.